|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM372471145 |
003 |
DE-627 |
005 |
20250306052558.0 |
007 |
cr uuu---uuuuu |
008 |
240518s2024 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1021/acs.langmuir.4c00657
|2 doi
|
028 |
5 |
2 |
|a pubmed25n1240.xml
|
035 |
|
|
|a (DE-627)NLM372471145
|
035 |
|
|
|a (NLM)38758706
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Zhang, Yaqin
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Label-free Colorimetric Detection of Viral RNA Based on Clustered Regularly Interspaced Short Palindromic Repeats and Gold Nanoparticles with a Portable Device
|
264 |
|
1 |
|c 2024
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 04.06.2024
|
500 |
|
|
|a Date Revised 04.06.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Viral infections, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are some of the most dangerous threats to humans. SARS-CoV-2 has caused a global pandemic, highlighting the unprecedented demand for rapid and portable diagnostic methods. To meet these requirements, we designed a label-free colorimetric platform that combines the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated proteins (Cas) 12a system for naked-eye detection (named LFP). This method utilizes reverse transcription loop-mediated isothermal amplification (RT-LAMP) and the trans-cleavage activity of the CRISPR/Cas12a system to increase the sensitivity and specificity of the reaction. This platform can detect as few as 4 copies/μL of RNA and produces no false positive results when tested against the influenza virus. To better meet the requirements of point-of-care (POC) detection, we developed a portable device that can be applied in resource-poor and densely populated regions. The LFP assay holds great potential for application in resource-limited settings, and the label-free gold nanoparticle (AuNPs) probe can reduce costs, making it suitable for large-scale screening. We expect that the LFP assay will be promising for the POC screening of COVID-19
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Gold
|2 NLM
|
650 |
|
7 |
|a 7440-57-5
|2 NLM
|
650 |
|
7 |
|a RNA, Viral
|2 NLM
|
700 |
1 |
|
|a Chen, Jianai
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kong, Fange
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Chunxia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Guo, Hangyu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Yingchun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lu, Jiahui
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Jicheng
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Jiasi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhou, Yulin
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1985
|g 40(2024), 22 vom: 04. Juni, Seite 11534-11540
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnas
|
773 |
1 |
8 |
|g volume:40
|g year:2024
|g number:22
|g day:04
|g month:06
|g pages:11534-11540
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1021/acs.langmuir.4c00657
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_721
|
951 |
|
|
|a AR
|
952 |
|
|
|d 40
|j 2024
|e 22
|b 04
|c 06
|h 11534-11540
|